Annals of Thoracic Surgery最新文献

筛选
英文 中文
Enhancing Graft Patency in Coronary Artery Bypass Grafting: Fluid Mechanics, Anastomotic Techniques, and Flow Dynamics 冠状动脉旁路移植术中增强移植物通畅:流体力学、吻合技术和血流动力学。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-19 DOI: 10.1016/j.athoracsur.2025.01.032
Yasunari Hayashi MD, Toshiaki Ito MD
{"title":"Enhancing Graft Patency in Coronary Artery Bypass Grafting: Fluid Mechanics, Anastomotic Techniques, and Flow Dynamics","authors":"Yasunari Hayashi MD, Toshiaki Ito MD","doi":"10.1016/j.athoracsur.2025.01.032","DOIUrl":"10.1016/j.athoracsur.2025.01.032","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 5","pages":"Page 1133"},"PeriodicalIF":3.6,"publicationDate":"2025-02-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143473315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editor's Choice 编辑器的选择
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-18 DOI: 10.1016/S0003-4975(25)00022-0
{"title":"Editor's Choice","authors":"","doi":"10.1016/S0003-4975(25)00022-0","DOIUrl":"10.1016/S0003-4975(25)00022-0","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 3","pages":"Page A8"},"PeriodicalIF":3.6,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429364","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Society Board 协会理事会
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-18 DOI: 10.1016/S0003-4975(25)00021-9
{"title":"Society Board","authors":"","doi":"10.1016/S0003-4975(25)00021-9","DOIUrl":"10.1016/S0003-4975(25)00021-9","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 3","pages":"Page A7"},"PeriodicalIF":3.6,"publicationDate":"2025-02-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143429363","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In Memoriam: David Fullerton, STS Past President and Superb Cardiac Surgeon, Educator, Investigator, and Leader (1952-2024) 悼念:大卫-富勒顿(David Fullerton),STS 前任主席、杰出的心脏外科医生、教育家、研究者和领导者(1952 - 2024)。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-13 DOI: 10.1016/j.athoracsur.2025.01.028
John Calhoon MD , Joe Cleveland MD , William Baumgartner MD
{"title":"In Memoriam: David Fullerton, STS Past President and Superb Cardiac Surgeon, Educator, Investigator, and Leader (1952-2024)","authors":"John Calhoon MD , Joe Cleveland MD , William Baumgartner MD","doi":"10.1016/j.athoracsur.2025.01.028","DOIUrl":"10.1016/j.athoracsur.2025.01.028","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 5","pages":"Pages 1126-1128"},"PeriodicalIF":3.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426702","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Future Is the Present, but Not Always the Past 未来就是现在,但并不总是过去。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-13 DOI: 10.1016/j.athoracsur.2025.02.001
Aaron Guo MD, Nahush Ashok Mokadam MD
{"title":"The Future Is the Present, but Not Always the Past","authors":"Aaron Guo MD, Nahush Ashok Mokadam MD","doi":"10.1016/j.athoracsur.2025.02.001","DOIUrl":"10.1016/j.athoracsur.2025.02.001","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 4","pages":"Pages 916-917"},"PeriodicalIF":3.6,"publicationDate":"2025-02-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426705","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Enhanced Survival With Surgical Ablation of Atrial Fibrillation During Mitral Valve Surgery. 在二尖瓣手术中通过手术消融心房颤动提高存活率
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-12 DOI: 10.1016/j.athoracsur.2025.01.026
John B Eisenga, Kyle B McCullough, Jasjit K Banwait, Timothy J George, Kelley A Hutcheson, Robert L Smith, J Michael DiMaio, Justin M Schaffer
{"title":"Enhanced Survival With Surgical Ablation of Atrial Fibrillation During Mitral Valve Surgery.","authors":"John B Eisenga, Kyle B McCullough, Jasjit K Banwait, Timothy J George, Kelley A Hutcheson, Robert L Smith, J Michael DiMaio, Justin M Schaffer","doi":"10.1016/j.athoracsur.2025.01.026","DOIUrl":"10.1016/j.athoracsur.2025.01.026","url":null,"abstract":"<p><strong>Background: </strong>Surgical ablation (SA) at the time of isolated mitral valve surgery (MVS) is recommended in patients with preexisting atrial fibrillation (AF). However, SA remains infrequently utilized during MVS with a poorly quantified impact on stroke and survival.</p><p><strong>Methods: </strong>Medicare claims (2008-2019) were queried to identify beneficiaries with preexisting AF undergoing MVS. All-cause mortality and the postoperative incidence of stroke/transient ischemic attack were evaluated as separate endpoints. Overlap propensity score weighting was used to risk-adjust for measured confounding variables. Analyses were repeated using surgeon frequency of SA as an instrumental variable to adjust for unmeasured confounding variables.</p><p><strong>Results: </strong>From 2008-2019, 41,795 Medicare beneficiaries with a preexisting diagnosis of AF underwent MVS. Surgeons were categorized, with 1326 infrequently (bottom quartile) performing SA (<30%; 10,364 beneficiaries) and 740 frequently (top quartile) performing SA (≥62%; 10,476 beneficiaries) during MVS. Beneficiaries undergoing MVS with SA (\"as-treated\" analysis) had a risk-adjusted median survival advantage of 0.56 (95% CI, 0.33-0.81) years (8.85 [95% CI, 8.64-9.04] vs 8.29 [95% CI, 8.11-8.47] years, P < .001 for risk-adjusted survival comparison) compared to those without. Beneficiaries undergoing MVS by frequent SA surgeons (\"surgeon-preference\" analysis) had a risk-adjusted median survival advantage of 0.35 (95% CI, 0.05-0.71) years (8.59 [95% CI, 8.40-8.85] vs 8.24 [95% CI, 7.97-8.40] years, P = .0015 for risk-adjusted survival comparison) compared to surgeons who infrequently performed SA.</p><p><strong>Conclusions: </strong>In Medicare beneficiaries with preexisting AF, concomitant SA during MVS is associated with improved survival, as is undergoing surgery by a frequent SA surgeon. When analyzed based on surgeon preference for SA, the magnitude and time-dependent nature of the treatment effect of SA were substantially different compared to the \"as-treated\" analysis, suggesting that \"as-treated\" analyses may be subject to bias from unmeasured confounding variables.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143426653","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ideal Timing of Coronary Artery Bypass Grafting After Non-ST-Segment Elevation Myocardial Infarction. 非st段抬高型心肌梗死后冠状动脉搭桥术的理想时机。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-11 DOI: 10.1016/j.athoracsur.2025.01.024
Anthony V Norman, Matthew P Weber, Mohamad El Moheb, Alexander M Wisniewski, Raymond J Strobel, Alan Speir, Michael Mazzeffi, Aarathi Manchikalapudi, Mark Joseph, Daniel Tang, Ramesh Singh, Mohammed Quader, Jared P Beller, Kenan Yount, Nicholas R Teman
{"title":"Ideal Timing of Coronary Artery Bypass Grafting After Non-ST-Segment Elevation Myocardial Infarction.","authors":"Anthony V Norman, Matthew P Weber, Mohamad El Moheb, Alexander M Wisniewski, Raymond J Strobel, Alan Speir, Michael Mazzeffi, Aarathi Manchikalapudi, Mark Joseph, Daniel Tang, Ramesh Singh, Mohammed Quader, Jared P Beller, Kenan Yount, Nicholas R Teman","doi":"10.1016/j.athoracsur.2025.01.024","DOIUrl":"10.1016/j.athoracsur.2025.01.024","url":null,"abstract":"<p><strong>Background: </strong>Patients with non-ST-segment elevation myocardial infarction (NSTEMI) benefit from revascularization, but guidelines are vague regarding optimal timing. This study aimed to identify the ideal timing of coronary artery bypass grafting (CABG) after NSTEMI.</p><p><strong>Methods: </strong>Study investigators examined patients with NSTEMI who underwent isolated CABG within 30 days of cardiac catheterization between July 2011 and July 2023 in a multicenter regional collaborative. Patients were stratified into 3 groups: ≤2 days, 3 to 7 days, and 8 to 30 days. Multivariable logistic regression analysis was performed to identify risk factors associated with mortality.</p><p><strong>Results: </strong>Study investigators identified 10,271 patients who underwent CABG: 3464 (34%) of these patients underwent CABG within ≤2 days, 5751 (56%) at 3 to 7 days, and 1056 (10%) at 8 to 30 days. The 3- to 7-day group had the lowest median The Society of Thoracic Surgeons predicted risk of mortality (1.36% vs 1.35% vs 2.09%; P < .001). The ≤2-day group more frequently presented with left main coronary artery disease (19% vs 16% vs 16%; P < .001) and cardiogenic shock (5.1% vs 1.8% vs 2%; P < .001). Mean cardiopulmonary bypass time was similar among the groups (97 minutes vs 97 minutes vs 97 minutes; P = .63). The 3- to 7-day group had the lowest operative mortality (3.2% vs 1.8% vs 4%; P < .001) and major morbidity (14% vs 11% vs 16%; P < .001). After risk-adjustment, the 3- to 7-day window was associated with decreased mortality compared with ≤2 days (odds ratio [OR], 0.56; 95% CI, 0.4-0.78; P < .001) and 8 to 30 days (OR, 0.51; 95% CI, 0.32-0.81; P < .001).</p><p><strong>Conclusions: </strong>CABG between 3 and 7 days after cardiac catheterization for NSTEMI was associated with the lowest risk of mortality. When possible, CABG within this window may afford better outcomes.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416190","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Minimally Invasive Valve Surgery for Patients With Infective Endocarditis: A Comparative Study 微创瓣膜手术治疗感染性心内膜炎的比较研究。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-11 DOI: 10.1016/j.athoracsur.2025.01.023
Connor Raikar BA , Stanley Wolfe MD, MPH , Luigi F. Lagazzi MD , Ali Darehzereshki MD , Nathan Kister MD , Lawrence Wei MD , Vinay Badhwar MD , J. Hunter Mehaffey MD, MS
{"title":"Minimally Invasive Valve Surgery for Patients With Infective Endocarditis: A Comparative Study","authors":"Connor Raikar BA ,&nbsp;Stanley Wolfe MD, MPH ,&nbsp;Luigi F. Lagazzi MD ,&nbsp;Ali Darehzereshki MD ,&nbsp;Nathan Kister MD ,&nbsp;Lawrence Wei MD ,&nbsp;Vinay Badhwar MD ,&nbsp;J. Hunter Mehaffey MD, MS","doi":"10.1016/j.athoracsur.2025.01.023","DOIUrl":"10.1016/j.athoracsur.2025.01.023","url":null,"abstract":"<div><h3>Background</h3><div>Patients with endocarditis frequently require valve surgical procedure, and despite the recent growth of minimally invasive cardiac surgery (MICS) for complex valve operations, consensus recommendations still suggest conventional sternotomy.</div></div><div><h3>Methods</h3><div>The institutional Adult Cardiac Surgery Database of The Society of Thoracic Surgeons (STS) evaluated all patients undergoing valve surgical procedure for endocarditis from July 2016 to March 2024. Patients were stratified by conventional sternotomy vs an MICS approach, including hemisternotomy, right thoracotomy, and robotic-assisted mitral, tricuspid, or aortic valve surgical procedure. Logistic regression assessed the risk-adjusted association with the primary outcomes of STS major morbidity or mortality and the MICS approach by accounting for all covariates in current STS risk models.</div></div><div><h3>Results</h3><div>Of 741 patients undergoing valve surgical procedure for endocarditis, the median age was 37 years, 582 (78.5%) had a substance use disorder, 210 (28.3%) underwent redo sternotomies, and 166 (22.4%) had redo valve operations. MICS was associated with a higher repair rate for mitral valves (76.3% vs 48%; <em>P</em> &lt; .0001) but a lower rate for tricuspid valve (22.5% vs 44.1%; <em>P</em> &lt; .0001), with no difference for aortic valves (8.3% vs 7.4%; <em>P</em> = .372). Before risk adjustment, MICS was associated with longer cross-clamp times (99 minutes vs 86 minutes; <em>P</em> = 0.019) but a lower incidence of STS major morbidity or mortality (15.4% vs 27.8%; <em>P</em> = 0.019). After robust risk adjustment, age (odds ratio [OR], 1.1; <em>P</em> = 0.008), lung disease (OR, 2.2; <em>P</em> = 0.010), preoperative creatinine (OR, 1.3; <em>P</em> = 0.016), and valve repair vs replacement (OR, 0.17; <em>P</em> = 0.002), but not MICS (OR, 1.2; <em>P</em> = 0.807), were independently associated with STS major morbidity and mortality.</div></div><div><h3>Conclusions</h3><div>MICS valve surgical procedure for endocarditis appears both safe and effective, with repair rates and risk-adjusted outcomes similar to those of open surgical procedure.</div></div>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":"119 5","pages":"Pages 1020-1026"},"PeriodicalIF":3.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Result of a Multicenter Study on the Physician-Modified Fenestrated and Branched Endovascular Grafts for Thoracoabdominal Aneurysms. 医师改良开窗支血管内移植治疗胸腹动脉瘤的多中心研究结果。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-11 DOI: 10.1016/j.athoracsur.2025.01.025
Guangmin Yang, Yepeng Zhang, Haiya Ni, Leiyang Zhang, Ping Wang, Xiaoqiang Li, Ming Zhang, Min Zhou
{"title":"Result of a Multicenter Study on the Physician-Modified Fenestrated and Branched Endovascular Grafts for Thoracoabdominal Aneurysms.","authors":"Guangmin Yang, Yepeng Zhang, Haiya Ni, Leiyang Zhang, Ping Wang, Xiaoqiang Li, Ming Zhang, Min Zhou","doi":"10.1016/j.athoracsur.2025.01.025","DOIUrl":"10.1016/j.athoracsur.2025.01.025","url":null,"abstract":"<p><strong>Background: </strong>Physician-modified fenestrated and branched endografts (PMEGs) have emerged as an endovascular solution for managing thoracoabdominal aortic aneurysms (TAAAs) in the past decade. This study evaluated the outcomes and experience of 3 high-volume centers.</p><p><strong>Methods: </strong>Patient data from 3 academic centers in China, spanning from 2017 and 2021, were retrospectively collected and analyzed. Early outcomes were assessed through perioperative morbidity and mortality. Follow-up outcomes included survival, freedom from reintervention, and patency of target vessels.</p><p><strong>Results: </strong>PMEG procedures were performed in 186 patients (156 men; mean age, 68.4 ± 13.4 years) with TAAAs. Fenestrations or branches were used to incorporate 618 target vessels. Postoperative all-cause mortality was 6.5%, with aneurysm-related deaths accounting for 1.6%. Morbidity included acute kidney injury (5.9%), stroke (1.1%), myocardial infarction (2.7%), and limb ischemia, respiratory failure, and bowel ischemia requiring resection (each 1.6%). Transient spinal cord injury developed in 1 patient. With a mean follow-up of 3.4 ± 1.3 years, survival rates were 96% at 1 year and 94% 3 years. The secondary patency rates of target vessels at 1 and 3 years were 99% and 98%, and freedom from reintervention was 95% and 91%, respectively.</p><p><strong>Conclusions: </strong>Fenestrated and branched endovascular aneurysm repair with PMEGs appears to be a safe and effective treatment for complex aortic aneurysms. Although early and midterm outcomes are promising and comparable to those of custom-made devices, further follow-up is essential to confirm long-term efficacy.</p>","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143416208","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conduit Selection in CABG surgery: Mounting RIMA Evidence is Challenging our Beliefs. 冠脉搭桥手术中的导管选择:越来越多的RIMA证据正在挑战我们的信念。
IF 3.6 2区 医学
Annals of Thoracic Surgery Pub Date : 2025-02-11 DOI: 10.1016/j.athoracsur.2025.01.027
Austin Browne, André Lamy
{"title":"Conduit Selection in CABG surgery: Mounting RIMA Evidence is Challenging our Beliefs.","authors":"Austin Browne, André Lamy","doi":"10.1016/j.athoracsur.2025.01.027","DOIUrl":"https://doi.org/10.1016/j.athoracsur.2025.01.027","url":null,"abstract":"","PeriodicalId":50976,"journal":{"name":"Annals of Thoracic Surgery","volume":" ","pages":""},"PeriodicalIF":3.6,"publicationDate":"2025-02-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143411465","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信